Back to Search
RICHARD NATALE, MD
MD
Urology Physician
NPI: 1700957677IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
2009-00461(NC)
CMS Specialties
PrimaryUROLOGY
Education
UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE
Class of 2004
Research & Publications (20)
Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii study.
PMID 19332730·J Clin Oncol·2009
3-trial
Dual targeting of the vascular endothelial growth factor receptor and epidermal growth factor receptor pathways with vandetinib (ZD6474) in patients with advanced or metastatic non-small cell lung cancer.
PMID 18520295·J Thorac Oncol·2008
4-observational
A ten-year review of progress in the treatment of non-small-cell lung cancer with gemcitabine.
PMID 16291427·Lung Cancer·2005
6-review
Epidermal growth factor receptor-targeted therapy with ZD1839: symptom improvement in non-small-cell lung cancer.
PMID 15142633·Int J Radiat Oncol Biol Phys·2004
6-review
Effects of ZD1839 (Iressa, gefitinib) treatment on symptoms and quality of life in patients with advanced non-small cell lung cancer.
PMID 15206079·Semin Oncol·2004
6-review
Gemcitabine-containing regimens vs others in first-line treatment of NSCLC.
PMID 15339056·Oncology (Williston Park)·2004
6-review
Inhibition of epidermal growth factor receptor and symptom improvement in advanced non-small cell lung cancer.
PMID 16088518·Semin Respir Crit Care Med·2004
8-other
Irinotecan, cisplatin/carboplatin, and COX-2 inhibition in small-cell lung cancer.
PMID 12886870·Oncology (Williston Park)·2003
6-review
Biologically targeted treatment of non-small-cell lung cancer: focus on epidermal growth factor receptor.
PMID 14641989·Clin Lung Cancer·2003
6-review
Birth can be a hazardous journey: electronic fetal monitoring does not help.
PMID 14663534·J Obstet Gynaecol Can·2003
8-other
Gemcitabine-based doublets for advanced non-small-cell lung cancer: beyond gemcitabine/cisplatin.
PMID 14720349·Clin Lung Cancer·2002
8-other
Gemcitabine and nonplatinum combinations in non-small-cell lung cancer.
PMID 11301844·Oncology (Williston Park)·2001
6-review
Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer.
PMID 11122869·Curr Oncol Rep·2000
6-review
Phase I/II trial of irinotecan, carboplatin, and paclitaxel in advanced or metastatic NSCLC.
PMID 10981288·Oncology (Williston Park)·2000
3-trial
Gemcitabine and taxane combinations in non small-cell lung cancer.
PMID 14725731·Clin Lung Cancer·2000
8-other
Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.
PMID 19349543·J Clin Oncol·2009
3-trial
Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.
PMID 19447868·Clin Cancer Res·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1084 VINEHAVEN DR
CONCORD, NC 28025 - Phone
- (704) 786-5131
Quick Facts
- NPI
- 1700957677
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 22
- Publications
- 20
Are you this provider?
Claim Your Profile